Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale 10% owner sold 130,364 shares at an average $27.97 ($3,645,758)
  2. 4 Other disposition Director disposed of 1,500,000 shares (other)
  3. 4 Other disposition 10% owner disposed of 1,500,000 shares (other)
  4. 4 Option exercise EVP, Research & CSO acquired 78,093 shares (option exercise)
  5. 4 Open-market sale Director sold 17,915 shares at $30.29 ($542,685)
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 8-K Event Other events
  9. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $30.00 ($150,000)
  10. 8-K Event Executive or director change
  11. 4 Open-market sale Director sold 5,000 shares at $30.00 ($150,000)
  12. 4 Open-market sale Director sold 17,915 shares at an average $29.06 ($520,694)
  13. 4 Open-market sale Chief Medical Officer sold 4,991 shares at $24.89 ($124,209)
  14. 4 Other disposition Director disposed of 3,374 shares (other)
  15. 4 Other disposition 10% owner disposed of 500,000 shares (other)
  16. 4 Other disposition Director disposed of 500,000 shares (other)
  17. 4 Open-market sale Director sold 17,915 shares at an average $25.84 ($462,976)
  18. 4 Other disposition Director disposed of 500,000 shares (other)
  19. 4 Other disposition 10% owner disposed of 500,000 shares (other)
  20. 8-K Event Material agreement

Page 21 of 41 · 806 filings